Takashi Morita Selected Research

Iodine-123

1/2022	Usefulness of the 2-year iodine-123 metaiodobenzylguanidine-based risk model for post-discharge risk stratification of patients with acute decompensated heart failure.
1/2021	Incremental prognostic value of cardiac metaiodobenzylguanidine imaging over the co-morbid burden in acute decompensated heart failure.
1/2020	Impact of adjunctive tolvaptan on sympathetic activity in acute heart failure with preserved ejection fraction.
12/2015	Risk stratification of patients with chronic heart failure using cardiac iodine-123 metaiodobenzylguanidine imaging: incremental prognostic value over right ventricular ejection fraction.
4/2011	Usefulness of cardiac iodine-123 meta-iodobenzylguanidine imaging to improve prognostic power of Seattle heart failure model in patients with chronic heart failure.
2/2009	Cardiac iodine-123 metaiodobenzylguanidine imaging predicts sudden cardiac death independently of left ventricular ejection fraction in patients with chronic heart failure and left ventricular systolic dysfunction: results from a comparative study with signal-averaged electrocardiogram, heart rate variability, and QT dispersion.
10/2007	Prediction of sudden death in patients with mild-to-moderate chronic heart failure by using cardiac iodine-123 metaiodobenzylguanidine imaging.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Takashi Morita Research Topics

Disease

25	Heart Failure 01/2022 - 06/2004
19	Myocardial Infarction 04/2022 - 01/2015
7	Neoplasms (Cancer) 01/2019 - 06/2004
6	ST Elevation Myocardial Infarction 04/2022 - 01/2017
6	Cardiovascular Diseases (Cardiovascular Disease) 01/2022 - 05/2018
5	Thrombosis (Thrombus) 01/2022 - 04/2009
5	Non-ST Elevated Myocardial Infarction 10/2021 - 01/2015
5	Chronic Renal Insufficiency 01/2021 - 10/2008
4	Stroke (Strokes) 10/2021 - 01/2019
4	Unstable Angina 01/2021 - 01/2015
4	Hemorrhage 05/2018 - 02/2002
3	Coronary Artery Disease (Coronary Atherosclerosis) 04/2022 - 11/2019
3	Death (Near-Death Experience) 01/2022 - 05/2018
3	Ventricular Tachycardia 12/2019 - 12/2015
3	Cardiac Sudden Death (Sudden Cardiac Arrest) 02/2019 - 02/2009
3	Fibrosis (Cirrhosis) 10/2017 - 09/2011
3	Infections 01/2016 - 01/2002
3	Glomerulonephritis 01/2016 - 05/2013
3	Genomic Instability 03/2009 - 03/2003
2	Atrial Fibrillation 01/2020 - 10/2017
2	Hypertension (High Blood Pressure) 01/2019 - 10/2017
2	Chronic Kidney Failure (Chronic Renal Failure) 01/2018 - 01/2016
2	Liver Diseases (Liver Disease) 05/2013 - 04/2002
2	Proteinuria 05/2013 - 12/2012
2	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 02/2011 - 08/2008
2	Sudden Death 07/2009 - 10/2007
2	Teratocarcinoma 06/2004 - 02/2002
2	Cardiomegaly (Heart Hypertrophy) 03/2002 - 01/2002
1	Anemia 10/2021
1	Peripheral Arterial Disease 10/2021
1	COVID-19 01/2021
1	Type 2 Diabetes Mellitus (MODY) 01/2021
1	Body Weight Changes 01/2020
1	Body Weight (Weight, Body) 01/2020
1	Weight Loss (Weight Reduction) 01/2020
1	Stable Angina 11/2019
1	Psoriasis (Pustulosis Palmaris et Plantaris) 09/2019
1	Arthritis (Polyarthritis) 09/2019
1	Psoriatic Arthritis 09/2019
1	Atopic Dermatitis (Atopic Eczema) 06/2019
1	Tachycardia (Tachyarrhythmias) 01/2019
1	Bradycardia 01/2019

Drug/Important Bio-Agent (IBA)

10	3-Iodobenzylguanidine (Iobenguane)IBA 01/2022 - 10/2007
7	Iodine-123IBA 01/2022 - 10/2007
6	omega-Chloroacetophenone (Mace)IBA 10/2021 - 05/2018
5	TroponinIBA 01/2021 - 01/2015
5	Creatine Kinase (Creatine Phosphokinase)IBA 09/2020 - 01/2015
5	Proteins (Proteins, Gene)FDA Link 01/2017 - 06/2004
4	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 05/2021 - 12/2006
4	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2016 - 06/2008
3	Everolimus FDA Link 10/2020 - 01/2019
3	ChromiumIBA 10/2020 - 01/2019
3	CobaltIBA 10/2020 - 01/2019
3	CreatinineIBA 08/2020 - 10/2008
2	Indicators and Reagents (Reagents)IBA 04/2021 - 09/2020
2	Brain Natriuretic Peptide (Natrecor)FDA Link 09/2020 - 01/2019
2	Tolvaptan FDA Link 01/2020 - 04/2017
2	DiureticsIBA 01/2020 - 04/2017
2	AlbuminsIBA 01/2019 - 10/2014
2	NitrogenIBA 01/2019 - 03/2018
2	Antineoplastic Agents (Antineoplastics)IBA 01/2019 - 04/2009
2	Urea (Carbamide)FDA LinkGeneric 01/2019 - 03/2018
2	2'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))IBA 08/2018 - 01/2017
2	Amlodipine (Norvasc)FDA LinkGeneric 10/2017 - 10/2014
2	DNA (Deoxyribonucleic Acid)IBA 11/2015 - 03/2003
2	CytoglobinIBA 04/2015 - 08/2011
2	GlobinsIBA 04/2015 - 08/2011
2	Peroxidase (Myeloperoxidase)IBA 05/2013 - 05/2013
2	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 05/2013 - 05/2013
2	Immunoglobulins (Immunoglobulin)IBA 05/2013 - 12/2012
2	CollagenIBA 08/2011 - 02/2002
2	Sodium Bicarbonate (Baking Soda)FDA LinkGeneric 04/2011 - 10/2008
2	Carrier Proteins (Binding Protein)IBA 06/2009 - 08/2005
2	Atorvastatin (Lipitor)FDA Link 06/2007 - 12/2006
2	Histones (Histone)IBA 06/2004 - 03/2003
2	Reactive Oxygen Species (Oxygen Radicals)IBA 03/2002 - 01/2002
1	Sirolimus (Rapamycin)FDA Link 04/2022
1	PolymersIBA 04/2022
1	tyramine-deoxysorbitolIBA 01/2022
1	empagliflozinIBA 01/2021
1	Phosphotransferases (Kinase)IBA 08/2020
1	Carotenoids (Carotene)IBA 09/2019
1	Vitamin A (Retinol)FDA LinkGeneric 09/2019
1	CarbohydratesIBA 06/2019
1	Niacin (Nicotinic Acid)FDA LinkGeneric 06/2019
1	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 06/2019
1	FatsIBA 06/2019
1	OilsIBA 06/2019
1	Vitamin B 6IBA 06/2019
1	Erlotinib Hydrochloride (CP 358,774)FDA Link 01/2019
1	Tyrosine Kinase InhibitorsIBA 01/2019
1	C-Reactive ProteinIBA 01/2019
1	Hemoglobins (Hemoglobin)IBA 01/2019

Therapy/Procedure

13	Therapeutics 01/2021 - 12/2006
7	Stents 04/2022 - 01/2017
5	Percutaneous Coronary Intervention 10/2021 - 01/2017
2	Secondary Prevention 10/2021 - 09/2020
2	Implantable Defibrillators (Implantable Cardioverter-Defibrillator) 12/2019 - 12/2015
1	Drug-Eluting Stents 10/2020
1	Catheter Ablation 01/2020